Company Profile
Summit Therapeutics Stock Price, News & Analysis
- Ticker:
- SMMT
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Summit Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
14.25 USD (-0.21%)
Close
Last updated: June 23, 2026 at 00:00
11.06B USD
Market cap
Why the stock is moving
SMMT is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Summit Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Summit Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Summit Therapeutics follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Summit Therapeutics sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Summit Therapeutics (SMMT)?
Summit Therapeutics (SMMT) most recently closed at 14.25 USD, a -0.21% move versus the previous session.
What is the market cap of Summit Therapeutics (SMMT)?
Summit Therapeutics currently has a market capitalization of 11.06B USD on BioPharmSignal.
What does Summit Therapeutics do?
Summit Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is SMMT stock listed?
Summit Therapeutics (SMMT) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Summit Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Summit?
Summit Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Summit Therapeutics targeting with Summit?
Summit Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Therapeutics?
Summit Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.